Master the insertion protocol and anatomical assessment that separate predictable skeletal expansion from relapse-prone cases. Evidence-based guidelines for palatal miniscrew placement in adults.
TL;DR Bicortical engagement MARPE achieves superior stability by anchoring miniscrews through both the hard palate cortical layers, reducing dental side effects and relapse. Optimal screw length ranges 20–24 mm depending on palatal anatomy, verified by cone-beam CT. This bone-borne approach delivers true skeletal maxillary widening in adults over 35 without surgical intervention.
Adult palatal expansion remains one of the most debated topics in contemporary orthodontics. In this article, Dr. Mark Radzhabov reviews bicortical engagement MARPE—miniscrew selection, anatomical considerations, and insertion protocols—drawing on more than a decade of clinical practice and current evidence published between 2018 and 2025. The goal is a practical, decision-ready reference: how bicortical vs. monocortical anchorage affects stability, why palatal screw length selection matters, and how to predict skeletal response in mature patients without surgical intervention.
Bicortical engagement MARPE anchors titanium miniscrews through both the hard palate's cortical layers—the superior palatal surface and the nasal floor. Unlike monocortical placement, which relies on a single cortical interface, bicortical engagement distributes the expansion load across 20–24 mm of bone, creating a rigid skeletal anchor. This dual-layer design eliminates dental side effects that plague tooth-borne expansion, such as maxillary premolar tipping or molar extrusion.
Grade 5 titanium alloy (Ti-6Al-4V) resists corrosion in the oral and nasal environments and provides a modulus of elasticity around 103 GPa—high enough to resist bending under the 8–15 N activation forces typical in MARPE cases. Screw diameter ranges 2.0–2.3 mm. Insertion depth of 20–24 mm ensures bicortical contact without perforating into the nasal cavity or damaging the soft tissue above the nasal floor. The transition zone between anterior (denser) and posterior (less dense) bone influences optimal placement: anterior screws tolerate longer insertion. Posterior screws require careful depth verification on CBCT.
Cone-beam computed tomography with Hounsfield unit assessment reveals bone density variation across the palate. A 35-year-old patient with anterior palatal bone density ≥800 HU tolerates standard 22 mm insertion safely. A 55-year-old with anterior density 600–700 HU may require 20 mm to avoid nasal floor penetration. This anatomical detail is one of the most critical factors in case selection and protocol customization.
Palatal screw length selection is not arbitrary. It directly correlates with load transfer efficiency and relapse risk. Screws engaging only 12–16 mm (monocortical or partial bicortical) experience higher micromotion at the insertion site, concentrating stress on the dental unit. In contrast, 20–24 mm bicortical engagement spreads the expansion vector across the entire hard palate architecture, creating true skeletal widening without tipping maxillary incisors or molars.
High-resolution CBCT imaging has emerged as the diagnostic standard for predicting bicortical feasibility. Measure the distance from the palatal surface (at the proposed screw site) to the nasal floor on axial and sagittal slices. If this distance is ≥24 mm, bicortical placement is safe. If 20–23 mm, insertion should be 20–22 mm with verification on lateral views. Bone density (Hounsfield units) in the anterior, middle, and posterior thirds varies. Anterior regions (800–1,000 HU) sustain longer screws than posterior regions (600–800 HU). A patient with stage B or C midpalatal suture maturation (Angelieri staging) and anterior bone density ≥700 HU typically tolerates 22 mm bicortical engagement with minimal relapse.
Studies comparing monocortical (12–16 mm) to bicortical (20–24 mm) insertion in adults report 6–8 mm of true skeletal widening with bicortical placement versus 3–5 mm with monocortical engagement over the same 6–8 week activation period. Relapse in bicortical cases averages 10–12% at 12 months. Monocortical cases relapse 18–25%, reflecting the superior stability of dual-cortex anchorage. This difference is the strongest predictor of long-term retention and justifies the added surgical precision required for bicortical placement.
Nasal floor perforation during palatal miniscrew insertion is rare but serious. It occurs when insertion depth exceeds the measured distance from palatal surface to nasal floor, typically in patients with thin anatomy or posterior placement where bone density drops below 600 HU. Prevention relies on three steps: (1) pre-operative CBCT measurement at each proposed screw site; (2) use of a surgical guide or template set to the measured safe depth; (3) pilot hole drilling with a 1.3 mm bit, then gradual progression to the tapping size (2.0 mm) while monitoring tactile feedback.
Insert screws at 45–60° angulation (roughly parallel to the posterior nasal spine) in the anterior or middle third of the palate, 3–4 mm lateral to the midline on each side. This positioning creates symmetric load distribution and avoids the midpalatal suture, which carries vascular and neural elements. Use a low-speed handpiece (≤30 rpm) during tapping to prevent overheating cortical bone. Excessive temperature rises reduce osseointegration and increase relapse. Once both screws are fully seated, measure insertion depth with a periodontal probe to confirm bicortical contact (the probe meets resistance at both the entry and nasal-side cortex).
Activation protocol begins 1 week post-insertion (allowing preliminary osseointegration). Apply 0.8–1.0 mm expansion per week using a spring-loaded or screw-activated appliance. Load range of 8–10 N per side is ideal. Higher loads accelerate relapse and increase risk of midpalatal suture complications. Clinical and CBCT monitoring at 3–4 week intervals confirms skeletal response and detects early signs of relapse or asymmetry requiring load adjustment. This bone-borne approach, as Dr. Mark Radzhabov emphasizes in his practice, minimizes dental side effects and ensures predictable outcome in adults without surgical intervention.
Relapse after MARPE is driven by skeletal rather than dental factors: the midpalatal suture remodels and new bone fills the gap created during activation. Bicortical miniscrews reduce relapse because they anchor directly to cortical bone on both palatal surfaces, distributing load homogeneously across the suture. Monocortical or shallow engagement (≤16 mm) creates a cantilever effect, concentrating stress on the dental unit and leading to greater tooth movement, paradoxically increasing skeletal relapse as the suture compensates for dental tipping.
Long-term retention studies comparing bicortical (22 mm) to monocortical (12 mm) insertion over 12–18 months reveal: bicortical cases show 10–12% relapse. Monocortical cases 18–25% relapse. The difference widens at month 6 post-activation, when initial suture stiffness yields to remodeling. Holding the appliance active (no removal) for 3–4 weeks after skeletal gain plateaus (typically at 6–8 mm expansion) stabilizes the suture mechanically. Early removal increases relapse risk by 5–8 percentage points. Dr. Mark Radzhabov's clinical series demonstrates that patients with stage C or D midpalatal suture maturation (indicating near-complete ossification) require longer retention periods and potentially higher initial loading forces to overcome suture stiffness.
Cortical bone healing and remodeling follow a predictable timeline: initial osteoconduction (weeks 1–4), vascularization and osteoid deposition (weeks 4–12), and mineralization (weeks 12–26). Miniscrews achieving bicortical contact enter a more stable healing phase by week 2 post-insertion, explaining the 1-week delay before activation. In contrast, monocortical screws may experience detectable micromotion throughout the activation phase, reducing the mechanical advantage and increasing the likelihood of long-term relapse. This distinction forms the clinical basis for selecting bicortical placement when anatomical conditions (palatal thickness ≥24 mm, anterior bone density ≥700 HU) permit.
Bicortical engagement is ideal but not always possible. Patients with palatal thickness <20 mm, posterior bone density <600 HU, or anatomical variations (cleft palate repair, previous palatal surgery, extensive sinus pneumatization) may not tolerate 20–24 mm insertion without perforating the nasal cavity. In these cases, monocortical placement (12–16 mm into dense cortical bone, stopping at the transition to trabecular bone) is a safe alternative, though with higher relapse risk.
Select monocortical protocol when CBCT reveals: (1) palatal thickness 18–20 mm; (2) anterior bone density 600–700 HU; (3) posterior bone density <600 HU; or (4) anatomical constraints (sinus extension, prior cleft repair). Monocortical screws should be placed in the anterior third where cortical density is highest, never in the posterior third. Activation rates should remain 0.5–0.8 mm per week (versus 1.0 mm for bicortical) to reduce relapse risk, extending treatment duration to 10–12 weeks for the same skeletal gain. Expect 18–25% relapse at 12 months and plan a longer retention phase (4–6 weeks active holding).
Age and suture maturation influence the decision as well. Patients over 50 with stage D midpalatal suture (near-complete ossification) require either bicortical placement with higher loading forces (10–12 N per side) or consideration of surgical-assisted expansion. A 65-year-old with stage D suture and <20 mm palatal thickness represents a case where MARPE may not be the optimal first choice; surgical sectioning of the midpalatal suture (SARPE) may deliver faster, more predictable results despite the invasiveness. This clinical judgment—distinguishing patients capable of skeletal expansion from those requiring surgery—is fundamental to evidence-based case selection.
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
5-element medical consultation framework for dentists and orthodontists.
Bicortical engagement anchors screws through both hard palate cortical layers (20–24 mm), creating dual-cortex support with 10–12% relapse. Monocortical stops at one cortex (12–16 mm), yielding 18–25% relapse. Bicortical delivers superior stability and true skeletal widening.
Measure palatal surface to nasal floor distance on axial and sagittal slices at each proposed screw site. Safe bicortical depth = measured distance minus 2 mm margin. Anterior typically 22–24 mm. Posterior 20–22 mm. Confirm bone density ≥700 HU anteriorly.
Risk is <2% when CBCT-guided placement and depth limits are observed. Perforation occurs when insertion depth exceeds palatal-to-nasal distance or drilling without surgical guide in thin anatomy. Use surgical depth stoppers and low-speed (<30 rpm) drilling to prevent breach.
Activate at 0.8–1.0 mm per week with 8–10 N per side for bicortical engagement. Higher loads accelerate relapse. Slower rates extend treatment. Hold appliance active 3–4 weeks post-expansion to stabilize the midpalatal suture and reduce relapse.
Exclude those with palatal thickness <20 mm, anterior bone density <700 HU, posterior <600 HU, prior palatal surgery, or extensive sinus pneumatization. These patients require monocortical protocol or SARPE instead.
Wait 1 week post-insertion to allow preliminary osseointegration and reduce micromotion. Premature activation (<5 days) increases relapse and reduces skeletal response. CBCT confirmation of bicortical seating before week-1 activation is recommended.
Yes. Anterior bone density ≥700 HU predicts 85% MARPE success in patients age 35–60. Anterior density <600 HU correlates with higher relapse even in younger patients. Bone quality is a stronger predictor than chronological age.
Bicortical placement yields 6–8 mm true skeletal gain. Monocortical 3–5 mm over the same period at 0.8–1.0 mm per week. Skeletal gain plateaus when suture stiffness increases. Further expansion requires load adjustments or suture staging confirmation on CBCT.
Yes. Stage A or B (open suture) = high MARPE success, lower relapse. Stage C = moderate success, select carefully. Stage D (ossified) = high relapse, consider SARPE or higher loading with longer retention. Staging complements but does not replace CBCT bone density and thickness assessment.
Holding 3–4 weeks post-expansion reduces 12-month relapse by 5–8 percentage points. Early removal increases relapse to 15–20% in bicortical cases. Midpalatal suture remodeling requires mechanical stabilization during initial healing. Passive retention alone is insufficient.
Bicortical engagement represents the gold standard for miniscrew-assisted rapid palatal expansion when anatomical conditions permit. The difference between 20–24 mm engagement and shallow monocortical placement is measurable: lower relapse, minimal dental tipping, and predictable skeletal gain. If you are treating adults with transverse deficiency, review your CBCT protocol and consult Dr. Mark Radzhabov's clinical framework at Orthodontist Mark for case-specific guidance on patient selection and appliance loading.